Insomnia: Therapeutic Options for Women

Sleep Medicine Clinics

Volumn 3, Issue 1, 2008, Pages 109-119

  Davidson, Judith R ^a,b  

^a QUEEN S UNIVERSITY   (Canada)

^b Kingston Family Health Team   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; BENZODIAZEPINE RECEPTOR STIMULATING AGENT; CHAMOMILE; DIPHENHYDRAMINE; ESZOPICLONE; HYPNOTIC AGENT; KAVA; LAVENDER OIL; MELATONIN; PLACEBO; RAMELTEON; TRAZODONE; VALERIAN; ZALEPLON; ZOLPIDEM; ZOPICLONE;

AUTOGENIC TRAINING; BALANCE DISORDER; BEHAVIOR THERAPY; CLINICAL TRIAL; COGNITIVE DEFECT; COGNITIVE THERAPY; CONFUSION; DISEASE PREDISPOSITION; DISORIENTATION; DIZZINESS; DROWSINESS; DRUG COST; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG RECEPTOR BINDING; DRUG SAFETY; DRUG TOLERABILITY; FALLING; FATIGUE; HEALTH CARE COST; HEART ARRHYTHMIA; HERBAL MEDICINE; HUMAN; INSOMNIA; MEDITATION; MEMORY DISORDER; MYALGIA; NAUSEA; PREVALENCE; PRIORITY JOURNAL; PSYCHOMOTOR DISORDER; PSYCHOTHERAPY; RELAXATION TRAINING; RESPIRATION DEPRESSION; REVIEW; RISK FACTOR; SEDATION; SIDE EFFECT; SOMNOLENCE; TERATOGENICITY; THERAPY EFFECT;

EID: 53349114309     PISSN: 1556407X     EISSN: 15564088     Source Type: Journal    
DOI: 10.1016/j.jsmc.2007.10.002     Document Type: Review

References (108)

1. American Sleep Disorders Association. The International classification of sleep disorders, revised: diagnostic and coding manual (1997), American Sleep Disorders Association, Rochester (MN)
2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th edition (1994), American Psychiatric Association, Washington, D.C.
3. World Health Organization. International statistical classification of diseases and related health problems 10th revision. Version for 2007.
4. Zammit G.K., Weiner J., Damato N., et al. Quality of life in people with insomnia. Sleep 22 (1999) S379-S385
5. Roth T., and Ancoli-Israel S. Daytime consequences and correlates of insomnia in the United States: results of the 1991 National Sleep Foundation Survey II. Sleep 22 (1999) S354-S358
6. Ford D.E., and Kamerow D.B. Epidemiologic study of sleep disturbances and psychiatric disorders. J Am Med Assoc 262 (1989) 1479-1484
7. Breslau N., Roth T., Rosenthal L., et al. Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults. Biol Psychiatry 39 (1996) 411-418
8. Roberts R.E., Shema S.J., Kaplan G., et al. Sleep complaints and depression in an aging cohort: a prospective perspective. Am J Psychiatry 157 (2000) 81-88
9. Perlis M.L., Giles D.E., Buysse D.J., et al. Self-reported sleep disturbance as a prodromal symptom in recurrent depression. J Affect Disord 42 (1997) 209-212
10. Simon G.E., and VonKorff M. Prevalance, burden, and treatment of insomnia in primary care. Am J Psychiatry 154 (1997) 1417-1423
11. Weissman M.M., Greenwald S., Nino-Murcia G., et al. The morbidity of insomnia uncomplicated by psychiatric disorders. Gen Hosp Psychiatry 19 (1997) 245-250
12. Weyerer S., and Dilling H. Prevalence and treatment of insomnia in the community: results from the Upper Bavarian field study. Sleep 14 (1991) 392-398
13. Spielman A.J., and Glovinsky P.B. Introduction: the varied nature of insomnia. In: Hauri P.J. (Ed). Case studies in insomnia (1991), Plenum, New York 1-15
14. Pearson N.J., Johnson L.L., and Nahin R.L. Insomnia, trouble sleeping, and complementary and alternative medicine. Arch Intern Med 166 (2006) 1775-1782
15. Leger D., Guilleminault C., Dreyfus J.P., et al. Prevalence of insomnia in a survey of 12,778 adults in France. J Sleep Res 9 (2000) 35-42
16. Stewart R., Besset A., Bebbington P., et al. Insomnia comorbidity and impact and hypnotic use by age group in a national survey population aged 16 to 74 years. Sleep 29 (2006) 1391-1397
17. Ohayon M.M., Caulet M., and Guilleminault C. How a general population perceives its sleep and how this relates to the complaint of insomnia. Sleep 20 (1997) 715-723
18. Morin C.M., Leblanc M., Daley M., et al. Epidemiology of insomnia: Prevalence, self-help treatments, consultations, and determinants of help-seeking behaviors. Sleep Med 7 (2006) 123-130
19. Liljenberg B., Almqvist M., Hetta J., et al. The prevalence of insomnia: the importance of operationally defined criteria. Ann Clin Res 20 (1988) 393-398
20. Ohayon M.M. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev 6 (2002) 97-111
21. Barsky A.J., Peekna H.M., and Borus J.F. Somatic symptom reporting in women and men. J Gen Intern Med 16 (2001) 266-275
22. Soares C.N. Insomnia in women: an overlooked epidemic?. Arch Womens Ment Health 8 (2005) 205-213
23. Bastien C., and Morin C.M. Familial incidence of insomnia. J Sleep Res 9 (2000) 49-54
24. Tjepkema M. Insomnia. Health Reports, Statistics Canada, Catalogue 82-003 17 (2005) 9-25
25. Espie C.A. Insomnia: conceptual issues in the development, maintenance and treatment of sleep disorder in adults. Annu Rev Psychol 53 (2002) 1-44
26. Vgontzas A.N., and Chrousos G.P. Sleep, the hypothalamic-pituitary-adrenal axis, and cytokines: multiple interactions and disturbances in sleep disorders. Endocrinol Metab Clin North Am 31 (2002) 15-36
27. Bastien C.H., Vallieres A., and Morin C.M. Precipitating factors of insomnia. Behav Sleep Med 2 (2004) 50-62
28. Healey E.S., Kales A., Monroe L.J., et al. Onset of insomnia: role of life-stress events. Psychosom Med 43 5 (1981) 439-451
29. Morin C.M., Rodrigue S., and Ivers H. Role of stress, arousal, and coping skills in primary insomnia. Psychosom Med 65 (2003) 259-267
30. Shaver J.L.F., Johnston S.K., Lentz M.J., et al. Stress exposure, psychological distress, and physiological stress activation in midlife women with insomnia. Psychosom Med 64 (2002) 793-802
31. Kageyama T., Kabuto M., Nitta H., et al. A population study on risk factors for insomnia among adult Japanese women: a possible effect of road traffic volume. Sleep 20 (1997) 963-971
32. Meijer A.M., and van den Wittenboer G.L.H. Contribution of infants' sleep and crying to marital relationship of first-time parent couples in the 1st year after childbirth. J Fam Psychol 21 (2007) 49-57
33. Meltzer L.J., and Mindell J.A. Relationship between child sleep disturbances and maternal sleep, mood, and parenting stress: a pilot study. J Fam Psychol 21 (2007) 67-73
34. Shaver J.L.F., and Zenk S.N. Sleep disturbance and menopause. J Womens Health Gend Based Med 9 (2000) 109-118
35. Savard J., Davidson J.R., Ivers H., et al. The association between nocturnal hot flashes and sleep in breast cancer survivors. J Pain Symptom Manage 27 (2004) 513-522
36. Kloss J.D., Tweedy K., and Gilrain K. Psychological factors associated with sleep disturbance among perimenopausal women. Behav Sleep Med 2 (2004) 177-190
37. Guilleminault C., Palombini L., Poyares D., et al. Chronic insomnia, postmenopausal women, and sleep disrodered breathing: part 1. Frequency of sleep disordered breathing in a cohort. J Psychosom Res 53 (2002) 611-615
38. Borbely A.A. Sleep mechanisms. Sleep Biol Rhythms 2 (2004) S67-S68
39. Robertson J.A., Broomfield N.M., and Espie C.A. Prospective comparison of subjective arousal during the pre-sleep period in primary sleep-onset insomnia and normal sleepers. J Sleep Res 16 (2007) 230-238
40. Dolder C., Nelson M., and McKinsey J. Use of non-benzodiazepine hypnotics in the elderly. Are all agents the same?. CNS Drugs 21 (2007) 389-405
41. Morin C.M., Culbert J.P., and Schwartz S.M. Nonpharmacological interventions for insomnia: a meta-analysis of treatment efficacy. Am J Psychiatry 151 (1994) 1172-1180
42. Kassam A., and Patten S.B. Hypnotic use in a population-based sample of over thirty-five thousand interviewed Canadians. Popul Health Metr 4 (2006) 10.1186/1478-7954-4-15
43. Smith M.T., Perlis M.L., Park A., et al. Comparative meta-analysis of pharmacotherapy and behaviour therapy for persistent insomnia. Am J Psychiatry 159 (2002) 5-11
44. Mendelson W.B., Roth T., Cassella J., et al. The treatment of chronic insomnia: drug indications, chronic use and abuse liability. Sleep Med Rev 8 (2004) 7-17
45. Najib J. Eszopiclone, a nonbenzodiazepine sedative-hypnotic agent for the treatment of transient and chronic insomnia. Clin Ther 28 (2006) 491-516
46. Holbrook A.M., Crowther R., Lotter A., et al. Meta-analysis of benzodiazephine use in the treatment of insomnia. Can Med Assoc J 162 (2000) 225-233
47. Montplaisir J., Hawa R., Moller H., et al. Zopiclone and zaleplon vs benzodiazepines in the treatment of insomnia: Canadian consensus statement. Hum Psychopharmacol 18 (2003) 29-38
48. Iqbal M.M., Sobhan T., and Ryals T. Effects of commonly used benzodiazepines on the fetus, the neonate, and the nursing infant. Psychiatr Serv 53 (2002) 39-49
49. Santiago J.R., Nolledo M.S., Kinzler W., et al. Sleep and sleep disorders in pregnancy. Ann Intern Med 134 (2001) 396-408
50. Glass J., Lanctot K.L., Herrmann N., et al. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. Br Med J 331 (2005) 1169
51. Benca R. Diagnosis and treatment of chronic insomnia: a review. Psychiatr Serv 56 (2005) 332-343
52. Swainston Harrison T., and Keating G.M. Zolpidem: a review of its use in the management of insomnia. CNS Drugs 19 (2005) 65-89
53. Dorsey C.M., Lee K.A., and Scharf M.B. Effect of zolpidem on sleep in women with perimenopausal and postmenopausal insomnia: a 4-week, randomized, multicenter, double-blind, placebo-controlled study. Clin Ther 26 (2004) 1578-1586
54. Melton S.T., Wood J.M., and Kirkwood C.K. Eszopiclone for insomnia. Ann Pharmacother 39 (2005) 1659-1665
55. Krystal A.D., Walsh J.K., Laska E., et al. Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia. Sleep 26 (2003) 793-799
56. Roth T., Walsh J.K., Krystal A.D., et al. An evaluation of the efficacy and safety of eszopiclone over 12 months in patients with chronic primary insomnia. Sleep Med 6 (2005) 487-495
57. Hajak G. A comparative assessment of the risks and benefits of zopiclone. A review of 15 years' clinical experience. Drug Saf 21 (1999) 457-469
58. Walsh J.K., Krystal A.D., Amato D.A., et al. Nightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life, and work limitations. Sleep 30 (2007) 959-968
59. Diav-Citrin O., Okotore B., Lucarelli K., et al. Pregnancy outcome following first-trimester exposure to zopiclone: a prospective controlled cohort study. Am J Perinatol 16 (1999) 157-160
60. Wyatt J.K., Dijk D.-J., Ritz-de Cecco A., et al. Sleep-facilitating effect of exogenous melatonin in healthy young men and women is circadian-phase dependent. Sleep 29 (2006) 609-618
61. Scheer F.A.J.L., and Czeisler C.A. Melatonin, sleep, and circadian rhythms. Sleep Med Rev 9 (2005) 5-9
62. Burgess H.J., Sharkey K.M., and Eastman C.I. Bright light, dark and melatonin can promote circadian adaptation in night shift workers. Sleep Med Rev 6 (2002) 407-420
63. Revell V.L., and Eastman C.I. How to trick mother nature into letting you fly around or stay up all night. J Biol Rhythms 20 (2005) 353-365
64. Roth T., Seiden D., Sainati S., et al. Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia. Sleep Med 7 (2006) 312-318
65. Erman M., Seiden D., Zammit G., et al. An efficacy, safety, and dose-response study of ramelteon in patients with chronic primary insomnia. Sleep Med 7 (2006) 17-24
66. Borja N.L., and Daniel K.L. Ramelteon for the treatment of insomnia. Clin Ther 28 (2006) 1540-1555
67. Rozerem (ramelteon) prescribing information. Available at: www.rozerem.com/index.aspx/PI.pdf. Accessed September 9, 2007.
68. Mendelson W.B. A review of the evidence for the efficacy and safety of trazodone in insomnia. J Clin Psychiatry 66 (2005) 469-476
69. Walsh J.K., Erman M., Erwin C.W., et al. Subjective hypnotic efficacy of trazodone and zolpidem. Hum Psychopharmacol 13 (1998) 191-198
70. Walsh J.K., and Schweitzer P.K. Ten-year trends in the pharmacological treatment of insomnia. Sleep 22 (1999) 371-375
71. James S.P., and Mendelson W.B. The use of trazodone as a hypnotic: a critical review. J Clin Psychiatry 65 (2004) 752-755
72. Kudo Y., and Kurihara M. Clinical evaluation of diphenhydramine hydrochloride for the treatment of insomnia in psychiatric patients: a double-blind study. J Clin Pharmacol 30 (1990) 1041-1048
73. Rickels K., Morris R.J., Newman H., et al. Diphenhydramine in insomniac family practice patients: a double-blind study. J Clin Psychiatry 23 (1983) 235-242
74. Morin C.M., Koetter U., Bastien C., et al. Valerian-hops combination and diphenhydramine for treating insomnia: a randomized placebo-controlled clinical trial. Sleep 28 (2005) 1465-1471
75. Halpert A.G., Olmstead M.C., and Beninger R.J. Mechanisms and abuse liability of the anti-histamine dimenhydrinate. Neurosci Biobehav Rev 26 (2002) 61-67
76. Richardson G.S., Roehrs T.A., Rosenthal L., et al. Tolerance to daytime sedative effects of H1 antihistamines. J Clin Pharmacol 22 (2002) 511-515
77. Wheatley D. Medicinal plants for insomnia: a review of their pharmacology, efficacy and tolerability. J Psychopharmacol 19 (2005) 414-421
78. Meoli A.L., Rosen C., Kristo D., et al. Oral nonprescription treatment for insomnia: an evaluation of products with limited evidence. J Clin Sleep Med 1 (2005) 173-187
79. Taibi D.M., Landis C.A., Petry H., et al. A systematic review of valerian as a sleep aid: safe but not effective. Sleep Med Rev 11 (2007) 209-230
80. Morin C.M., Gaulier B., Barry T., et al. Patients' acceptance of psychological and pharmacological therapies for insomnia. Sleep 15 (1992) 302-305
81. Morin C.M., Colecchi C., Stone J., et al. Behavioral and pharmacological therapies for late-life insomnia. A randomized controlled trial. J Am Med Assoc 281 (1999) 991-999
82. Aber R., and Webb W.B. Effects of a limited nap on night sleep in older subjects. Psychol Aging 1 (1986) 300-302
83. Aschoff J. Naps as integral parts of the wake time within the human sleep-wake cycle. J Biol Rhythms 9 (1994) 145-155
84. Morin C.M., Bootzin R.R., Buysse D.J., et al. Psychological and behavioral treatment of insomnia: update of the recent evidence (1998-2004). Sleep 29 (2006) 1398-1414
85. Lai H.-L., and Good M. Music improves sleep quality in older adults. J Adv Nurs 49 (2005) 234-244
86. Johnson J.E. The use of music to promote sleep in older women. J Community Health Nurs 20 (2003) 27-35
87. Morin C.M., and Espie C.A. Insomnia: a clinical guide to assessment and treatment (2003), Kluwer Academic / Plenum Publishers, New York
88. Riedel B.W., and Lichstein K.L. Insomnia and daytime functioning. Sleep Med Rev 4 (2000) 277-298
89. Murtagh D.R.R., and Greenwood K.M. Identifying effective psychological treatments for insomnia: a meta-analysis. J Consult Clin Psychol 63 (1995) 79-89
90. Morgenthaler T., Kramer M., Alessi C., et al. Practice parameters for the psychological and behavioural treatment of insomnia: an update. An American Academy of Sleep Medicine report. Sleep 29 (2006) 1415-1419
91. Schoicket S.L., Bertelson A.D., and Lacks P. Is sleep hygiene a sufficient treatment for sleep-maintenance insomnia?. Behav Ther 19 (1988) 183-190
92. Engle-Friedman M., Bootzin R.R., Hazlewood L., et al. An evaluation of behavioral treatments for insomnia in the older adult. J Clin Psychol 48 (1992) 77-90
93. Cheek R.E., Shaver J.L., and Lentz M.J. Lifestyle practices and nocturnal sleep in midlife women with and without insomnia. Biol Res Nurs 6 (2004) 46-58
94. Vallieres A., Bastien C.H., Ouellet M., et al. Cognitive-behaviour therapy for insomnia associated with anxiety or depression. [abstract]. Sleep 23 Suppl 2 (2000) A311
95. Bastien C., Morin C., Ouellet M.-C., et al. Cognitive-behavioral therapy for insomnia: comparison of individual therapy, group therapy, and telephone consultations. J Consult Clin Psychol 72 (2004) 653-659
96. Strom L., Pettersson R., and Andersson G. Internet-based treatment for insomnia: A controlled evaluation. J Consult Clin Psychol 72 (2004) 113-120
97. Morin C.M., Beaulieu-Bonneau S., Leblanc M., et al. Self-help treatment for insomnia: A randomized controlled trial. Sleep 28 (2005) 1319-1327
98. Irwin M.R., Cole J.C., and Nicassio P.M. Comparative meta-analysis of behavioral interventions for insomnia and their efficacy in middle-aged adults and in older adults 55+ years of age. Health Psychol 25 (2006) 3-14
99. Smith M.T., Huang M.I., and Manber R. Cognitive behavior therapy for chronic insomnia occurring within the context of medical and psychiatric disorders. Clin Psychol Rev 25 (2005) 559-592
100. National Institute of Health State of the Science Conference statement; manifestations and management of chronic insomnia in adults. Sleep 28 (2005) 1049-1057
101. Currie S.R., Wilson K.G., Pontefract A.J., et al. Cognitive-behavioral treatment of insomnia secondary to chronic pain. J Consult Clin Psychol 68 (2000) 407-416
102. Savard J., Simard S., Ivers H., et al. Randomized study of the efficacy of cognitive-behavioural therapy for insomnia secondary to breast cancer, Part I: sleep and psychological effects. Am J Clin Oncol 23 (2005) 6083-6096
103. Morawetz D. Insomnia and depression: Which comes first?. Sleep Res Online 5 (2003) 77-81
104. Dashevsky B., and Kramer M. Behavioral treatment of chronic insomnia in psychiatrically ill patients. J Clin Psychiatry 59 (1998) 693-699
105. Hickey M., Davis S.R., and Sturdee D.W. Treatment of menopausal symptoms: What shall we do now?. Lancet 366 (2005) 409-421
106. Taylor D.J., Mallory L.J., Lichstein K.L., et al. Comorbidity of chronic insomnia with medical problems. Sleep 30 (2007) 213-218
107. Espie C.A., Inglis S.J., Tessier S., et al. The clinical effectiveness of cognitive behaviour therapy for chronic insomnia: implementation and evaluation of a sleep clinic in general medical practice. Behav Res Ther 39 (2001) 45-60
108. Davidson J.R., Feldman-Stewart D., Brennenstuhl S., et al. How to provide insomnia interventions to people with cancer: insights from patients. Psychooncology 16 11 (2007) 1028-1038